Indications and Usage
SPRIX® (ketorolac tromethamine) is indicated in adult patients for the short term (up to 5 days) management of moderate to
moderately severe pain that requires analgesia at the opioid level.
- Sprix is not for use in pediatric patients less than 2 years of age.
Spray was demonstrated by a statistically significant
reduction in pain vs placebo in an acute pain study of
post-abdominal or -orthopedic surgery patients and in a
second study of post-abdominal surgery patients1-4
across multiple pain areas
PAIN MANAGEMENT
Acute and post-procedural/surgical pain
Fax completed Scripts Rx form to (844) 794-7275. Write clearly to help automate
processing so the prescription will reach your patients faster.
Oakbrook Terrace, IL 60181
eligible commercial insurance
required for patients with eligible
commercial insurance
without contact to your patient’s home
ABOUT SPRIX: OPIOID-LEVEL ANALGESIA1
A nasal spray formulation of ketorolac, an NSAID (nonsteroidal anti-inflammatory drug), and a proven pain reliever
SPRIX is for short-term (up to 5 days) pain relief in adult patients to manage
moderate to moderately severe pain that requires analgesia at the opioid level1
SPRIX is a potent NSAID and is NOT a controlled substance
Ketorolac strength in the speed of a nasal spray.
Efficacy within 20-30 minutes2,3
PATIENT PROFILES: ADULT PATIENTS WHO EXPERIENCE ACUTE PAIN
SPRIX is a non-narcotic medication delivering short-term (for up to 5 days) opioid-level analgesia to manage
moderate to moderately severe pain that requires analgesia at the opioid level1
Acute Onset of Pain
Lisa, Computer Programmer
Pain history
None
Presenting concern
Acute onset of moderate knee pain after gardening over the weekend
Physician assessment
Level of pain requires the short-term management (up to 5 days) of
analgesia at the opioid level
Conclusion
Prescribe 1 carton of SPRIX, with 5 single-day bottles, to provide treatment
for her moderate acute pain
Dosage and Administration
- Use the lowest effective dosage for shortest duration consistent with individual treatment goals
- SPRIX is not an inhaled product. For adult patients < 65 years of age: 31.5 mg (one 15.75 mg spray in each nostril) every 6 to 8
hours. The maximum daily dose is 126 mg - For patients ≥ 65 years of age, renally impaired patients, and patients less than 50 kg (110 lbs): 15.75 mg (one 15.75 mg spray in
only one nostril) every 6 to 8 hours. The maximum daily dose is 63 mg - SPRIX nasal spray should be discarded within 24 hours of taking the first dose, even if the bottle still contains some medication
